Bisphosphonates and the jaw repercussions: A narrative review
DOI:
https://doi.org/10.33448/rsd-v10i9.17923Keywords:
Bisphosphonates; Osteonecrosis; Jaw.Abstract
Bisphosphonates are drugs that act by decreasing and inhibiting osteoclastic activity, and inducing cell apoptosis. They block osteoclast differentiation and stimulate osteoblasts, resulting in decreased bone resorption. It may contribute to the exposure of necrotic bone in the maxillofacial region. Thus, this narrative review proposes a brief discussion about the development of osteonecrosis of the maxillary bones resulting from therapy with bisphosphonates. Having as the theme the development of osteonecrosis in the jaws resulting from the use of bisphosphonates, we searched through the MeSH terms and DeCS/MeSH terms, between 2006 and 2021, for articles in English and Portuguese indexed in the MEDLINE/PubMed database, Web of Science, LILACS/bvs as well as through a manual search. After analysis the selected articles, it was observed that the possibility of the development of osteonecrosis in the maxillary bones is multifactorial, thus it is imperative to approach these sites with a preventive way and with a minimally invasive therapy.
References
Allen, M. R., & Burr, D. B. (2008). Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons, 66(5), 987–994. https://doi.org/10.1016/j.joms.2008.01.038
AlRahabi, M. K., & Ghabbani, H. M. (2018). Clinical impact of bisphosphonates in root canal therapy. Saudi medical journal, 39(3), 232–238. https://doi.org/10.15537/smj.2018.3.20923
Aparecida Cariolatto, F., Carelli, J., de Campos Moreira, T., Pietrobon, R., Rodrigues, C., & Bonilauri Ferreira, A. P. (2018). Recommendations for the Prevention of Bisphosphonate-Related Osteonecrosis of the Jaw: A Systematic Review. The journal of evidence-based dental practice, 18(2), 142–152. https://doi.org/10.1016/j.jebdp.2017.11.002
Arce, K., Assael, L. A., Weissman, J. L., & Markiewicz, M. R. (2009). Imaging findings in bisphosphonate-related osteonecrosis of jaws. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons, 67(5 Suppl), 75–84. https://doi.org/10.1016/j.joms.2008.12.002
Barin, L. M., Pillusky, F. M., Pasini, M. M., Denesi, C. C. (2016) Osteonecrose dos maxilares associada ao uso de bifosfonatos: uma revisão de literatura. Revista de Odontologia da Universidade Cidade de São Paulo, 28(2), 126-134. ISSN 1983-5183
Biasotto, M., Chiandussi, S., Dore, F., Rinaldi, A., Rizzardi, C., Cavalli, F., & Di Lenarda, R. (2006). Clinical aspects and management of bisphosphonates-associated osteonecrosis of the jaws. Acta odontologica Scandinavica, 64(6), 348–354. https://doi.org/10.1080/00016350600844360
Bodem, J. P., Schaal, C., Kargus, S., Saure, D., Mertens, C., Engel, M., Hoffmann, J., & Freudlsperger, C. (2016). Surgical management of bisphosphonate-related osteonecrosis of the jaw stages II and III. Oral surgery, oral medicine, oral pathology and oral radiology, 121(4), 367–372. https://doi.org/10.1016/j.oooo.2015.10.033
Borjaille, B.P., Brandão, L.R., Hasegawa, T.M., Rosa, R. F., Antonio, S.F., Chahade, W. H., (2006). Osteonecrose e Síndrome da Imunodeficiência Adquirida. Rev. Bras. Reumatol, 46, suppl.1,36-44.
Brozoski, M. A., Traina, A. A., Deboni, M. C. Z., Marques, M. M., Naclério-Homem, M. da G. (2012). Osteonecrose maxilar associada ao uso de bifosfonatos. Rev Bras Reumatol 2012;52(2):260-270.
Cardoso, C. L., Barros, C. A., Curra, C., Fernandes, L. M. P. da S. R., Franzolin, S. de O. B., Júnior, J. S. F., Curi, M. M. (2017). Radiographic Findings in Patients with Medication-Related Osteonecrosis of the Jaw. International Journal of Dentistry, 2017, 1–6. doi:10.1155/2017/3190301
Chang, J., Hakam, A. E., & McCauley, L. K. (2018). Current Understanding of the Pathophysiology of Osteonecrosis of the Jaw. Current osteoporosis reports, 16(5), 584–595. https://doi.org/10.1007/s11914-018- 0474-4
Chapurlat, R. D., & Delmas, P. D. (2006). Drug insight: Bisphosphonates for postmenopausal osteoporosis. Nature clinical practice. Endocrinology & metabolism, 2(4), 211–238. https://doi.org/10.1038/ncpendmet0121
Chaves, R. A. da C., Órfão, A. M. A., Júnior, W. B., Queiroz, T. P., & Faloni, A. P. (2018). Bifosfonatos e Denosumabes: mecanismos de ação e algumas implicações para a implantodontia. Revista Brasileira Multidisciplinar, 21(2), 66-80. https://doi.org/10.25061/2527-2675/ReBraM/2018.v21i2.483
Christou, J., Johnson, A. R., & Hodgson, T. A. (2013). Bisphosphonate-related osteonecrosis of the jaws and its relevance to children--a review. International journal of paediatric dentistry, 23(5), 330–337. https://doi.org/10.1111/ipd.12047
Coelho, A. I., Gomes, P. De S., Fernandes, M. H. (2010) Osteonecrose dos maxilares associada ao uso de bifosfonatos. Parte I: etiologia e apresentação clínica. Revista Portuguesa de Estomatologia, Medicina Dentária e Cirurgia Maxilofacial, 51(2), 95-101. https://doi.org/10.1016/S1646-2890(10)70093-5
Costa, L. L. R., Mendes, T. M., Santos, L. S., Mendes, P. H. C. (2019). Análise do conhecimento e da conduta médica acerca da prevenção da osteonecorose dos maxilares pelo uso de bifosfonatos. Revista da Universidade Vale do Rio Verde, 17(1),1-8. http://dx.doi.org/10.5892/ruvrd.v17i1.4981
Crépin, S., Laroche, M. L., Sarry, B., & Merle, L. (2010). Osteonecrosis of the jaw induced by clodronate, an alkylbiphosphonate: case report and literature review. European journal of clinical pharmacology, 66(6), 547–554. https://doi.org/10.1007/s00228-010-0822-5
Cunha, K. S., Lippert, V. F., Baldino, M. E. L., Dreyer, J. W., Cunha, R. M. (2019) Alternativa de tratamento reabilitador para pacientes em uso de bisfosfonato intravenoso: relato de caso clinico. Revista Odontológica de Araçatuba, 40(1), 29-34. ISSN 2357-8378 e 1677-6704
De Moraes, S. L. C., Afonso, A. M. P., Santos, R. G. S., Mattos, R. P., Oliveira, M. T. F., Zanetta-Barbosa, D., Duarte, B. G. (2014) Riscos e complicações para os ossos da face decorrentes do uso de bifosfonatos. Revista Brasileira de Odontologia, 70(2), 114-119. ISSN 1984-3747.
De Oliveira, M. A., Martins, M. F., Asah, D. A., Santos, P. S., Gallotini, M. (2014) Osteonecrose induzida por Bifosfonatos: relato de caso clínico e protocolo de atendimento/Osteonecrosis induced by bisphosphonates: case study and protocol service. Arquivos Médicos dos Hospitais e da Faculdade de Ciências Médicas da Santa Casa de São Paulo, 59(1), 43-48.
De Sousa, A. S., Taitra, V. P. A. J., Saveda, L. F., Rodrigues, I. V., Giro, G. (2018) Protocolo de atendimento odontológico de pacientes em tratamento com bifosfonatos. Revista Saúde-UNG-Ser, 12(1/2,), 54-61. http://dx.doi.org/10.33947/1982-3282-v12n1-2-3278
Devogelaer, J. P., Brown, J. P., Burckhardt, P., Meunier, P. J., Goemaere, S., Lippuner, K., Body, J. J., Samsioe, G., Felsenberg, D., Fashola, T., Sanna, L., Ortmann, C. E., Trechsel, U., Krasnow, J., Eriksen, E. F., & Garnero, P. (2007). Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 18(9), 1211–1218. https://doi.org/10.1007/s00198-007-0367-3
Dotto, A. C.& Dotto, A. C. (2011) Osteonecrose dos maxilares induzida por Bifosfonatos–revisão de literatura e relato de caso. Revista da Faculdade de Odontologia-UPF,16(2),229-233.
Duarte, N. T., Rech, B. de O., Martins, I. G., Franco, J. B., & Ortega, K. L. (2019). Can children be affected by bisphosphonate-related osteonecrosis of the jaw? A systematic review. International Journal of Oral and Maxillofacial Surgery. doi:10.1016/j.ijom.2019.08.004
Endo, Y., Kumamoto, H., Nakamura, M., Sugawara, S., Takano-Yamamoto, T., Sasaki, K., & Takahashi, T. (2017). Underlying Mechanisms and Therapeutic Strategies for Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ). Biological & pharmaceutical bulletin, 40(6), 739–750. https://doi.org/10.1248/bpb.b16-01020
Etminan, M., Aminzadeh, K., Matthew, I. R., & Brophy, J. M. (2008). Use of oral bisphosphonates and the risk of aseptic osteonecrosis: a nested case-control study. The Journal of rheumatology, 35(4), 691–695.
Fedele, S., Porter, S. R., D'Aiuto, F., Aljohani, S., Vescovi, P., Manfredi, M., Arduino, P. G., Broccoletti, R., Musciotto, A., Di Fede, O., Lazarovici, T. S., Campisi, G., & Yarom, N. (2010). Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series. The American journal of medicine, 123(11), 1060–1064. https://doi.org/10.1016/j.amjmed.2010.04.033
Ferreira Jr, L. H., Jr, Mendonça Jr, K. D., Jr, Chaves de Souza, J., Soares Dos Reis, D. C., do Carmo Faleiros Veloso Guedes, C., de Souza Castro Filice, L., Bruzadelli Macedo, S., & Soares Rocha, F. (2021). Bisphosphonate-associated osteonecrosis of the jaw. Minerva dental and oral science, 70(1), 49–57. https://doi.org/10.23736/S0026-4970.20.04306-X
Fliefel, R., Tröltzsch, M., Kühnisch, J., Ehrenfeld, M., & Otto, S. (2015). Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review. International journal of oral and maxillofacial surgery, 44(5), 568–585. https://doi.org/10.1016/j.ijom.2015.01.026
Frascino, A., & Forte, A. (2016). Interação dos Bifosfonatos na Cirurgia Odontológica. Atas de Ciências da Saúde, 4(1), 12-22. http://revistaseletronicas.fmu.br/index.php/ACIS/article/view/1069
Gavalda, C., & Bagan, J. (2016). Concept, diagnosis and classification of bisphosphonate-associated osteonecrosis of the jaws. A review of the literature. Medicina Oral Patología Oral y Cirugia Bucal, e260– e270. doi:10.4317/medoral.21001
Granate-Marques, A., Polis-Yanes, C., Seminario-Amez, M., Jané-Salas, E., & López-López, J. (2019). Medication-related osteonecrosis of the jaw associated with implant and regenerative treatments: Systematic review. Medicina oral, patologia oral y cirugia bucal, 24(2), e195–e203. https://doi.org/10.4317/medoral.22691
Grbic, J. T., Landesberg, R., Lin, S. Q., Mesenbrink, P., Reid, I. R., Leung, P. C., Casas, N., Recknor, C. P., Hua, Y., Delmas, P. D., Eriksen, E. F., & Health Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly Pivotal Fracture Trial Research Group (2008). Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial. Journal of the American Dental Association (1939), 139(1), 32–40. https://doi.org/10.14219/jada.archive.2008.0017
Guo, Z., Cui, W., Que, L., Li, C., Tang, X., & Liu, J. (2020). Pharmacogenetics of medication-related osteonecrosis of the jaw: a systematic review and meta-analysis. International journal of oral and maxillofacial surgery, 49(3), 298–309. https://doi.org/10.1016/j.ijom.2019.07.016
Hagelauer, N., Pabst, A. M., Ziebart, T., Ulbrich, H., & Walter, C. (2014). In vitro effects of bisphosphonates on chemotaxis, phagocytosis, and oxidative burst of neutrophil granulocytes. Clinical Oral Investigations, 19(1), 139–148. 10.1007/s00784-014-1219-0
He, L., Sun, X., Liu, Z., Qiu, Y., & Niu, Y. (2020). Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw. International journal of oral science, 12(1), 30. https://doi.org/10.1038/s41368-020-00093-2
Izquierdo, C. M., Oliveira, M. G., Weber, B. B. J. (2011) Terapêutica com Bifosfonatos: implicações no paciente odontológico: revisão de literatura. RFO UPF 16(3),347-352.
Junior, C. D. F., Casado, P. L., Barboza, E. S. P. (2007) Osteonecrose associada aos bifosfonatos na odontologia. Periodontia ; 17(4): 24-30.
Junior, H. H. T., Almeida, J. S., Mourão, C. F., Meira, R., Ribeiro, J. (2016) Avaliação qualitativa do tratamento da osteonecrose dos maxilares associada aos bifosfonatos: aspectos atuais da literatura. Ciência Atual–Revista Científica Multidisciplinar do Centro Universitário São José, 8(2),02-11.
Kalra, S., & Jain, V. (2013). Dental complications and management of patients on bisphosphonate therapy: A review article. Journal of oral biology and craniofacial research, 3(1), 25–30. https://doi.org/10.1016/j.jobcr.2012.11.001
Kates, S. L., & Ackert-Bicknell, C. L. (2016). How do bisphosphonates affect fracture healing?. Injury, 47 Suppl 1(0 1), S65–S68. https://doi.org/10.1016/S0020-1383(16)30015-8
Khan, A. A., Morrison, A., Hanley, D. A., Felsenberg, D., McCauley, L. K., O'Ryan, F., Reid, I. R., Ruggiero, S. L., Taguchi, A., Tetradis, S., Watts, N. B., Brandi, M. L., Peters, E., Guise, T., Eastell, R., Cheung, A. M., Morin, S. N., Masri, B., Cooper, C., Morgan, S. L., International Task Force on Osteonecrosis of the Jaw (2015). Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research, 30(1), 3–23. https://doi.org/10.1002/jbmr.2405
Khan, A. A., Rios, L. P., Sándor, G. K., Khan, N., Peters, E., Rahman, M. O., Clokie, C. M., Dore, E., & Dubois, S. (2011). Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons. The Journal of rheumatology, 38(7), 1396–1402. https://doi.org/10.3899/jrheum.100221
Khan, A. A., Sándor, G. K., Dore, E., Morrison, A. D., Alsahli, M., Amin, F., Peters, E., Hanley, D. A., Chaudry, S. R., Lentle, B., Dempster, D. W., Glorieux, F. H., Neville, A. J., Talwar, R. M., Clokie, C. M., Mardini, M. A., Paul, T., Khosla, S., Josse, R. G., Sutherland, S., … Canadian Taskforce on Osteonecrosis of the Jaw (2009). Bisphosphonate associated osteonecrosis of the jaw. The Journal of rheumatology, 36(3), 478–490. https://doi.org/10.3899/jrheum.080759
Khosla, S., Burr, D., Cauley, J., Dempster, D. W., Ebeling, P. R., Felsenberg, D., Gagel, R. F., Gilsanz, V., Guise, T., Koka, S., McCauley, L. K., McGowan, J., McKee, M. D., Mohla, S., Pendrys, D. G., Raisz, L. G., Ruggiero, S. L., Shafer, D. M., Shum, L., Silverman, S. L., … American Society for Bone and Mineral Research (2007). Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research, 22(10), 1479–1491. https://doi.org/10.1359/jbmr.0707onj
Kim, J. E., Yoo, S., & Choi, S. C. (2020). Several issues regarding the diagnostic imaging of medication-related osteonecrosis of the jaw. Imaging science in dentistry, 50(4), 273–279. https://doi.org/10.5624/isd.2020.50.4.273
Leite, G. B., Louro, R., Vivacqua, C. F. P. P., Motta, S. H. G. (2015) Osteonecrose induzida pelo uso de Bifosfonatos após instalação de implantes dentários–relato de caso. ImplantNews,12(6): 771-778.
Lyles, K. W., Colón-Emeric, C. S., Magaziner, J. S., Adachi, J. D., Pieper, C. F., Mautalen, C., Hyldstrup, L., Recknor, C., Nordsletten, L., Moore, K. A., Lavecchia, C., Zhang, J., Mesenbrink, P., Hodgson, P. K., Abrams, K., Orloff, J. J., Horowitz, Z., Eriksen, E. F., Boonen, S., & HORIZON Recurrent Fracture Trial (2007). Zoledronic acid and clinical fractures and mortality after hip fracture. The New England journal of medicine, 357(18), 1799–1809. https://doi.org/10.1056/NEJMoa074941
Mariotti A. (2008). Bisphosphonates and osteonecrosis of the jaws. Journal of dental education, 72(8), 919–929.
Matsuura, T., Tokutomi, K., Sasaki, M., Katafuchi, M., Mizumachi, E., & Sato, H. (2014). Distinct characteristics of mandibular bone collagen relative to long bone collagen: relevance to clinical dentistry. BioMed research international, 2014, 769414. https://doi.org/10.1155/2014/769414
Moinzadeh, A. T., Shemesh, H., Neirynck, N. A., Aubert, C., & Wesselink, P. R. (2013). Bisphosphonates and their clinical implications in endodontic therapy. International endodontic journal, 46(5), 391–398. https://doi.org/10.1111/iej.12018
Moreno-Rabié, C., Gaêta-Araujo, H., Oliveira-Santos, C., Politis, C., & Jacobs, R. (2020). Early imaging signs of the use of antiresorptive medication and MRONJ: a systematic review. Clinical oral investigations, 24(9), 2973–2989. https://doi.org/10.1007/s00784-020-03423-0
Mourão, C. F. A. B., Moura, A. P., Manso, J. E. F. (2013) Tratamento da osteonecrose dos maxilares associada aos bifosfonatos: revisão da literatura. Rev Bras Cir Cabeça Pescoço, 42(2), 113-117. https://www.researchgate.net/publication/284717613
Ogura I, Minami Y, Ono J, Kanri Y, Okada Y, Igarashi K, Haga-Tsujimura M, Nakahara K, Kobayashi E. CBCT imaging and histopathological characteristics of osteoradionecrosis and medicationrelated osteonecrosis of the jaw. Imaging Sci Dent. 51(1):73- 80. https://doi.org/10.5624/isd.20200230
Ogura I, Minami Y, Ono J, Kanri Y, Okada Y, Igarashi K, Haga-Tsujimura M, Nakahara K, Kobayashi E. CBCT imaging and histopathological characteristics of osteoradionecrosis and medicationrelated osteonecrosis of the jaw. Imaging Sci Dent. 51(1):73-80. https://doi.org/10.5624/isd.20200230
Otto, S., Hafner, S., & Grötz, K. A. (2009). The role of inferior alveolar nerve involvement in bisphosphonate-related osteonecrosis of the jaw. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons, 67(3), 589–592. https://doi.org/10.1016/j.joms.2008.09.028
Otto, S., Pautke, C., Hafner, S., Hesse, R., Reichardt, L. F., Mast, G., Ehrenfeld, M., & Cornelius, C. P. (2013). Pathologic fractures in bisphosphonate-related osteonecrosis of the jaw-review of the literature and review of our own cases. Craniomaxillofacial trauma & reconstruction, 6(3), 147–154. https://doi.org/10.1055/s-0033-1343776
Papadakis, I., Spanou, A., & Kalyvas, D. (2021). Success Rate and Safety of Dental Implantology in Patients Treated With Antiresorptive Medication: A Systematic Review. The Journal of oral implantology, 47(2), 169–180. https://doi.org/10.1563/aaid-joi-D-19-00088
Papapoulos, S. E. (2008). Bisphosphonates: how do they work?. Best practice & research. Clinical endocrinology & metabolism, 22(5), 831–847. https://doi.org/10.1016/j.beem.2008.07.001
Passeri, L. A., Bértolo, M. B., Abuabara, A. (2011) Osteonecrose dos maxilares associada ao uso de Bifosfonatos. Revista Brasileira de Reumatologia, 51(4), 404-407. SSN: 1809-4570
Pazianas, M., Blumentals, W. A., & Miller, P. D. (2008). Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 19(6), 773–779. https://doi.org/10.1007/s00198-007-0547-1
Poubel, V. L. N., Cruz, D. S. M., Gil, L. F., Júnior, N. L. Claus, J. D. P., Gil, J. N. (2012) Osteonecrose maxilo-mandibular induzida por bisfosfonato: revisão bibliográfica. Revista de Cirurgia e Traumatologia Buco-maxilo-facial, 12(1),33-42. ISSN 1808-5210.
Powell, D., Bowler, C., Roberts, T., Garton, M., Matthews, C., McCall, I., & Davie, M. (2012). Incidence of serious side effects with intravenous bisphosphonate: a clinical audit. QJM: monthly journal of the Association of Physicians, 105(10), 965–971. https://doi.org/10.1093/qjmed/hcs112
Querrer, R., Ferrare, N., Melo, N., Stefani, C. M., Dos Reis, P., Mesquita, C., Borges, G. A., Leite, A. F., & Figueiredo, P. T. (2021). Differences between bisphosphonate-related and denosumab-related osteonecrosis of the jaws: a systematic review. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 29(6), 2811–2820. https://doi.org/10.1007/s00520-020-05855-6
Rasmusson, L., & Abtahi, J. (2014). Bisphosphonate associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment. International journal of dentistry, 2014, 471035. https://doi.org/10.1155/2014/471035
Reich, W., Bilkenroth, U., Schubert, J., Wickenhauser, C., & Eckert, A. W. (2015). Surgical treatment of bisphosphonate-associated osteonecrosis: Prognostic score and long-term results. Journal of cranio-maxillo-facial surger: official publication of the European Association for Cranio-Maxillo-Facial Surgery, 43(9), 1809–1822. https://doi.org/10.1016/j.jcms.2015.07.035
Rigo, R. F., Gomes, F. V., Mayer, L. (2017) Osteonecrose perimplantar relacionada ao uso de bifosfonatos: revisão de literatura. Revista da AcBO, 6(1), 31-37.
Rother, E. . Revisão sistemática X revisão narrativa. Acta paul. enferm., 20(2), v-vi, https://doi.org/10.1590/S0103-21002007000200001
Ruggiero, S. L., & Woo, S. B. (2008). Biophosphonate-related osteonecrosis of the jaws. Dental clinics of North America, 52(1), 111–ix. https://doi.org/10.1016/j.cden.2007.09.002
Ruggiero, S. L., Dodson, T. B., Assael, L. A., Landesberg, R., Marx, R. E., Mehrotra, B., & American Association of Oral and Maxillofacial Surgeons (2009). American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons, 67(5 Suppl), 2–12. https://doi.org/10.1016/j.joms.2009.01.009
Ruggiero, S. L., Dodson, T. B., Fantasia, J., Goodday, R., Aghaloo, T., Mehrotra, B., O'Ryan, F., & American Association of Oral and Maxillofacial Surgeons (2014). American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. Journal of oral and maxillofacial surgery:fficial journal of the American Association of Oral and Maxillofacial Surgeons, 72(10),1938–1956. https://doi.org/10.1016/j.joms.2014.04.031
Sacco, R., Woolley, J., Yates, J., Calasans-Maia, M. D., Akintola, O., & Patel, V. (2021). A systematic review of metastatic cancer presenting in osteonecrosis of the jaws (MC-ONJ) in patients undergoing antiresorptive and/or antiangiogenic therapy for skeletal-related adverse events. Oral surgery, oral medicine, oral pathology and oral radiology, 131(6), 650–659. https://doi.org/10.1016/j.oooo.2021.01.001
Sales, K. O., Conceição, L. S. (2020) A atuação do cirurgião-dentista frente à osteonecrose dos maxilares associada ao uso de bifosfonatos: uma revisão de literatura. Original Article. J Business Techn, 14(2),99-110. ISSN 2526-4281
Santos de Souza, E., de Jesus Santos, J., & Botelho de Santana, L. L. (2019). Impactos associados ao uso prolongado de bifosfonatos no tratamento da osteoporose em idosos. Revista Textura, 12(20),151-161. https://doi.org/10.22479/desenreg2018v12n20p151-161
Santos, L. C. S., Pereira, R. P., Gusmão, J. M. R., Almeida, O. D. S. (2016). Influência do uso de Bifosfonatos em pacientes submetidos a implantes dentários: revisão de literatura. Revista Bahiana de Odontologia, Salvador, 7(1), 22-30. http://2238-2720revbahianaodonto.v7i1.706
Santos, P. S. S., Oliveira, M. A., Felix, V. B. (2011) Osteonecrose maxilofacial induzida por Bifosfonatos em indivíduos com osteoporose. Revista Brasileira de Ortopedia,46(5), 495-499, https://doi.org/10.1590/S0102-36162011000500003
Sarasquete, M. E., González, M., San Miguel, J. F., & García-Sanz, R. (2009). Bisphosphonate-related osteonecrosis: genetic and acquired risk factors. Oral diseases, 15(6), 382–387. https://doi.org/10.1111/j.1601-0825.2009.01568.x
Sawatari, Y., & Marx, R. E. (2007). Bisphosphonates and bisphosphonate induced osteonecrosis. Oral and maxillofacial surgery clinics of North America, 19(4), 487–vi. https://doi.org/10.1016/j.coms.2007.07.003
Sérgio Perri de Carvalho, P., Fernandes Santos, H., Gomes Duarte, B., Astolphi Carvalho, F., Dias-Ribeiro, E., & Ferreira Rocha, J. (2010). Principais aspectos da cirurgia bucomaxilofacial no paciente sob terapia com bifosfonatos. Revista Da Faculdade De Odontologia - UPF, 15(2). https://doi.org/10.5335/rfo.v15i2.1351
Sharma, D., Ivanovski, S., Slevin, M., Hamlet, S., Pop, T. S., Brinzaniuc, K., Petcu, E. B., & Miroiu, R. I. (2013). Bisphosphonate-related osteonecrosis of jaw (BRONJ): diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effect. Vascular cell, 5(1), 1. https://doi.org/10.1186/2045-824X-5-1
Srinivasan, D., Shetty, S., Ashworth, D., Grew, N., & Millar, B. (2007). Orofacial pain - a presenting symptom of bisphosphonate associated osteonecrosis of the jaws. British dental journal, 203(2), 91–92. https://doi.org/10.1038/bdj.2007.635
Srivastava, A., Nogueras Gonzalez, G. M., Geng, Y., Won, A. M., Cabanillas, M. E., Naing, A., Myers, J. N., Li, Y., & Chambers, M. S. (2021). Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: systematic review and meta-analysis. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 29(5), 2305–2317. https://doi.org/10.1007/s00520-020-05882-3
Stockmann, P., Ebker, T., Bergauer, J., & Wehrhan, F. (2020). Saliva diagnostics in patients suffering from bisphosphonate-associated osteonecrosis of the jaw: Results of an observational study. Journal of craniomaxillo-facial surgery: official publication of the European Association for Cranio-Maxillo-Facial Surgery, 48(2), 176–180. https://doi.org/10.1016/j.jcms.2020.01.005
Stramandinoli-Zanicotti, R. T., Deliberador, T. M., Schussel, J., Torres-Pereira, C., Sassi, L. M. (2018) Implantes dentários em pacientes usuários de bifosfonatos: o risco de osteonecrose e perda dos implantes é real? Relato de três casos clínicos. RSBO, 15(1),50-9. https://www.researchgate.net/publication/328137190
Tavares Junior, H. H., Almeida, J. S., Mourão, C. F., Meira, R., Ribeiro, J. (2016) Avaliação qualitativa do tratamento da osteonecrose dos maxilares associada aos bifosfonatos: aspectos atuais da literatura. Ciênc Atual, 8(2),02-11.
Tennis, P., Rothman, K. J., Bohn, R. L., Tan, H., Zavras, A., Laskarides, C., Calingaert, B., & Anthony, M. S. (2012). Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis. Pharmacoepidemiology and drug safety, 21(8), 810–817. https://doi.org/10.1002/pds.3292
Thumbigere-Math, V., Michalowicz, B. S., Hodges, J. S., Tsai, M. L., Swenson, K. K., Rockwell, L., & Gopalakrishnan, R. (2014). Periodontal Disease as a Risk Factor for Bisphosphonate-Related Osteonecrosis of the Jaw. Journal of Periodontology, 85(2), 226–233. doi:10.1902/jop.2013.130017
Tsao, C., Darby, I., Ebeling, P. R., Walsh, K., O’Brien-Simpson, N., Reynolds, E., & Borromeo, G. (2013). Oral Health Risk Factors for Bisphosphonate-Associated Jaw Osteonecrosis. Journal of Oral and Maxillofacial Surgery, 71(8), 1360–1366. doi:10.1016/j.joms.2013.02.016
Ulmner, M., Jarnbring, F., & Törring, O. (2014). Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons, 72(1), 76–82. https://doi.org/10.1016/j.joms.2013.06.221
Vilela-Carvalho, L. N., Tuany-Duarte., N., Andrade-Figueiredo, M., López-Ortega, K. Osteonecrosis de los maxilares relacionados con el uso de medicamentos: Diagnóstico, tratamiento y prevención. Rev. CES Odont 2018; 31(2), 48-63. http://dx.doi.org/10.21615/cesodon.31.2.5
Walter, C., Laux, C., & Sagheb, K. (2013). Radiologic bone loss in patients with bisphosphonate-associated osteonecrosis of the jaws: a case–control study. Clinical Oral Investigations, 18(2), 385– 390. doi:10.1007/s00784-013-0974-7
Wan, J. T., Sheeley, D. M., Somerman, M. J., & Lee, J. S. (2020). Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors. Bone research, 8(1), 14. https://doi.org/10.1038/s41413-020-0088-1
Wasserzug, O., Kaffe, I., Lazarovici, T. S., Weissman, T., Yahalom, R., Fliss, D. M., & Yarom, N. (2017). Involvement of the maxillary sinus in bisphosphonate-related osteonecrosis of the jaw: Radiologic aspects. American journal of rhinology & allergy, 31(1), 36–39. https://doi.org/10.2500/ajra.2017.31.4395
Zadik, Y., Benoliel, R., Fleissig, Y., & Casap, N. (2012). Painful trigeminal neuropathy induced by oral bisphosphonate-related osteonecrosis of the jaw: a new etiology for the numb-chin syndrome. Quintessence international (Berlin, Germany : 1985), 43(2), 97–104. PMID: 22257870
Zhang, X., Hamadeh, I. S., Song, S., Katz, J., Moreb, J. S., Langaee, T. Y., Lesko, L. J., & Gong, Y. (2016). Osteonecrosis of the Jaw in the United States Food and Drug Administration's Adverse Event Reporting System (FAERS). Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 31(2), 336–340. https://doi.org/10.1002/jbmr.2693
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Michelly Cauás de Queiroz Gatis; Aldson dos Santos Silva; Maria Luiza Alcoforado Ribeiro; Davi Barbirato; Elizabeth Carneiro de Arruda Ponzi; José Brasiliense Holanda Cavalcanti Filho; Carlos Augusto Pereira do Lago; Belmiro Cavalcanti do Egito Vasconcelos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
